Endophleban en es it fr

Endophleban Brand names, Endophleban Analogs

Endophleban Brand Names Mixture

  • No information avaliable

Endophleban Chemical_Formula

C33H37N5O5

Endophleban RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Endophleban fda sheet

Endophleban FDA

Endophleban msds (material safety sheet)

Endophleban MSDS

Endophleban Synthesis Reference

No information avaliable

Endophleban Molecular Weight

583.678 g/mol

Endophleban Melting Point

No information avaliable

Endophleban H2O Solubility

No information avaliable

Endophleban State

Solid

Endophleban LogP

No information avaliable

Endophleban Dosage Forms

Liquid

Endophleban Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Endophleban Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Endophleban Absorption

Interpatient variable and may be dependent on the administration technique

Endophleban side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Endophleban Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Endophleban Organisms Affected

Humans and other mammals